Flagship Pioneering
Biotech Investor · 3 portfolio companies
Portfolio
3
Combined Value
$21.9B
Focus Areas
8
Top Stage
Commercial
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Moderna | $20.4B |
| Generate Biomedicines | $1.6B |
| Alltrna | — |
Biotech Investor · 3 portfolio companies
| Company | Valuation |
|---|---|
| Moderna | $20.4B |
| Generate Biomedicines | $1.6B |
| Alltrna | — |